Evidence map›Paper›PMID 29344520›Full record

ArticleVisceral medicine2017

Did the International ALPPS Meeting 2015 Have an Impact on Daily Practice? The Hamburg Barmbek Experience of 58 Cases.

Gregor A Stavrou, Marcello Donati, Mohammad H Fard-Aghaie, Martin Zeile, Tessa M Huber, Axel Stang, Karl J Oldhafer

Open access · bronzeAbstract read
In one paragraph

Article in Visceral medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Frontiers of Liver Surgery.Visceral medicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Gregor A StavrouGeneral and Visceral Surgery, Surgical Oncology, Asklepios Hospital Barmbek, Hamburg, Germany.
Marcello DonatiGeneral and Visceral Surgery, Surgical Oncology, Asklepios Hospital Barmbek, Hamburg, Germany.
Mohammad H Fard-AghaieGeneral and Visceral Surgery, Surgical Oncology, Asklepios Hospital Barmbek, Hamburg, Germany.
Martin ZeileSemmelweis Medical Faculty, Campus Hamburg, Hamburg, Germany.
Tessa M HuberGeneral and Visceral Surgery, Surgical Oncology, Asklepios Hospital Barmbek, Hamburg, Germany.
Axel StangSemmelweis Medical Faculty, Campus Hamburg, Hamburg, Germany.
Karl J OldhaferGeneral and Visceral Surgery, Surgical Oncology, Asklepios Hospital Barmbek, Hamburg, Germany.
MSH Medical School Hamburg – University of Applied Sciences and Medical University · DEAsklepios Klinik Barmbek · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundALPPS (associating liver partition and portal vein ligation for staged hepatectomy) was introduced only 10 years ago and has gained wide acceptance as a variation of staged procedures in liver surgery. It has been criticized for its high morbidity and mortality, which all centers reported in their initial series.

methodsAfter a world expert meeting in Hamburg in 2015 where all experts in the field met to discuss this method, caveats were extracted and formulated. We researched our complete prospective ALPPS database to see if the recommendations had any impact on outcome.

resultsIn total, we performed 58 ALPPS procedures in our center. 33 patients were operated on before, 25 after the meeting. Results in terms of morbidity and mortality were significantly better after the meeting, as were patient selection and strategy.

conclusionIn our own center's experience, the implementation of the meetings' recommendations and the information gathered through this valuable exchange had a dramatic impact on results. Having performed 58 ALPPS procedures in total, we can now conclude that ALPPS has become much safer in our hands since the 2015 meeting and that morbidity and mortality are no longer the issue to be discussed. Future research must focus on oncologic outcomes in these patients.

Indexed as

ALPPSIn-situ splitLiverTwo-stage

Identifiers

PMID29344520
PMCPMC5757589
OpenAlexW2769659064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.